{"id":"https://openalex.org/W1987533745","doi":"https://doi.org/10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6","title":"A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma","display_name":"A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma","publication_year":1994,"publication_date":"1994-06-01","ids":{"openalex":"https://openalex.org/W1987533745","doi":"https://doi.org/10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6","mag":"1987533745","pmid":"https://pubmed.ncbi.nlm.nih.gov/8194022"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6","doi":"https://doi.org/10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Eric J. Small","raw_affiliation_strings":["Department of Medicine, University of California, San Francisco 94143-0324","Department of Medicine, UCSF/Mt. Zion Medical Center, San Francisco, California","Division of Clinical Pharmacy, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of California, San Francisco 94143-0324","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Department of Medicine, UCSF/Mt. Zion Medical Center, San Francisco, California","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]},{"raw_affiliation_string":"Division of Clinical Pharmacy, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037047203","display_name":"John W. Frye","orcid":"https://orcid.org/0000-0002-7869-7181","observed_orcids":["https://orcid.org/0000-0002-7869-7181"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John W. Frye","raw_affiliation_strings":["Department of Nursing, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nursing, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113933530","display_name":"Mary J. Wilkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary J. Wilkinson","raw_affiliation_strings":["Department of Medicine, UCSF/Mt. Zion Medical Center, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, UCSF/Mt. Zion Medical Center, San Francisco, California","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056969058","display_name":"Peter R. Carroll","orcid":"https://orcid.org/0000-0002-1086-4334","observed_orcids":["https://orcid.org/0000-0002-1086-4334","https://orcid.org/0000-0001-9659-2976","https://orcid.org/0000-0001-7233-8156"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter R. Carroll","raw_affiliation_strings":["Department of Urology, UCSF/Mt. Zion Medical Center, San Francisco, California","Genitourinary Malignancy Service, UCSF/Mt. Zion Medical Center, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, UCSF/Mt. Zion Medical Center, San Francisco, California","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]},{"raw_affiliation_string":"Genitourinary Malignancy Service, UCSF/Mt. Zion Medical Center, San Francisco, California","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111531032","display_name":"Mary Lou Ernest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Lou Ernest","raw_affiliation_strings":["Department of Nursing, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nursing, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002429484","display_name":"Robert Stagg","orcid":"https://orcid.org/0009-0009-3797-0151","observed_orcids":["https://orcid.org/0009-0009-3797-0151"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Stagg","raw_affiliation_strings":["Division of Clinical Pharmacy, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacy, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007578304"],"corresponding_institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.16399612,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"11","first_page":"2803","last_page":"2807"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/5-fluorodeoxyuridine","display_name":"5-fluorodeoxyuridine","score":0.9670000076293945},{"id":"https://openalex.org/keywords/vinblastine","display_name":"vinblastine","score":0.9750000238418579},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.9100000262260437},{"id":"https://openalex.org/keywords/alternating-chemotherapy","display_name":"alternating chemotherapy","score":0.6060000061988831},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7760000228881836},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6840000152587891},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.8309999704360962},{"id":"https://openalex.org/keywords/catheter-related-complications","display_name":"catheter-related complications","score":0.7089999914169312},{"id":"https://openalex.org/keywords/prior-nephrectomy","display_name":"prior nephrectomy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.3919999897480011}],"concepts":[{"id":"https://openalex.org/C2777132456","wikidata":"https://www.wikidata.org/wiki/Q282629","display_name":"Vinblastine","level":3,"score":0.8634861707687378},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7940795421600342},{"id":"https://openalex.org/C2779598120","wikidata":"https://www.wikidata.org/wiki/Q5462356","display_name":"Floxuridine","level":4,"score":0.7489502429962158},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6186870336532593},{"id":"https://openalex.org/C2777027219","wikidata":"https://www.wikidata.org/wiki/Q1284190","display_name":"Constant (computer programming)","level":2,"score":0.6004741191864014},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.48141929507255554},{"id":"https://openalex.org/C3018112808","wikidata":"https://www.wikidata.org/wiki/Q640448","display_name":"Continuous infusion","level":2,"score":0.46903786063194275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34001463651657104},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2868615388870239},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.24026522040367126},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005467","descriptor_name":"Floxuridine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007263","descriptor_name":"Infusions, Parenteral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6","doi":"https://doi.org/10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:8194022","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8194022","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1522696994","https://openalex.org/W1771969015","https://openalex.org/W1779966086","https://openalex.org/W1822789550","https://openalex.org/W1835824883","https://openalex.org/W1914884493","https://openalex.org/W1939353013","https://openalex.org/W1942070062","https://openalex.org/W1967580525","https://openalex.org/W1975568557","https://openalex.org/W1982615063","https://openalex.org/W1986336518","https://openalex.org/W1995206692","https://openalex.org/W2010922182","https://openalex.org/W2018481354","https://openalex.org/W2036852386","https://openalex.org/W2043488870","https://openalex.org/W2247895695","https://openalex.org/W2295246435","https://openalex.org/W2408263508","https://openalex.org/W2412037637","https://openalex.org/W2415529413","https://openalex.org/W2416786277","https://openalex.org/W2438926143","https://openalex.org/W2474019072","https://openalex.org/W4233911200"],"related_works":["https://openalex.org/W2018481354","https://openalex.org/W2094752661","https://openalex.org/W2007306986","https://openalex.org/W1914884493","https://openalex.org/W2097134027","https://openalex.org/W1996073734","https://openalex.org/W2057993204","https://openalex.org/W1984581372","https://openalex.org/W2736205024","https://openalex.org/W2405242833"],"abstract_inverted_index":{"BACKGROUND:":[0],"Metastatic":[1],"renal":[2],"cell":[3,12],"carcinoma":[4],"(RCC)":[5],"is":[6,227,238,243,252],"largely":[7],"chemoresistant.":[8],"The":[9,58,103],"efficacy":[10,68],"of":[11,28,43,61,96,158,164,232],"cycle":[13,104],"specific":[14],"chemotherapeutic":[15],"agents,":[16],"particularly":[17],"those":[18],"with":[19,55,75,80,249,263],"short":[20],"half-lives,":[21],"may":[22],"be":[23,257],"enhanced":[24],"by":[25,91],"the":[26,118,202,230,246],"use":[27,60],"constant":[29,81,93,218,223],"rate":[30,42,82,94,219,224],"infusion":[31,83,95,220,225],"schedules.":[32],"Infusional":[33,46],"floxuridine":[34,110,184,196,221,242,265],"has":[35,48],"been":[36,50],"demonstrated":[37],"to":[38,66,195,199,240,256],"have":[39],"a":[40,92,179],"response":[41],"approximately":[44],"20%.":[45],"vinblastine":[47,112,208,226],"not":[49],"tested":[51],"extensively":[52],"in":[53,168,175,229],"patients":[54,74,130,147,176],"metastatic":[56,76,233],"RCC.":[57,234],"sequential":[59],"these":[62],"agents":[63],"was":[64,126,160,185,197,209],"designed":[65],"increase":[67],"and":[69,109,111,142,171,188,222],"limit":[70],"toxicity.":[71],"METHODS:":[72],"Fifteen":[73],"RCC":[77],"were":[78,114,136,213],"treated":[79],"floxuridine,":[84],"0.075":[85],"mg/kg/day":[86,187],"for":[87,100,123,138,151,183,189,207],"14":[88,101],"days,":[89],"followed":[90],"vinblastine,":[97,190],"0.7":[98,191],"mg/m2/day":[99],"days.":[102,162],"repeated":[105],"every":[106],"28":[107],"days":[108],"doses":[113],"incrementally":[115],"increased":[116],"until":[117],"maximum":[119],"tolerated":[120],"dose":[121],"(MTD)":[122],"each":[124],"patient":[125],"reached.":[127],"RESULTS:":[128],"Four":[129],"had":[131,148,178],"partial":[132],"responses":[133,166,173],"(27%),":[134],"which":[135],"maintained":[137],"3,":[139],"9,":[140],"16":[141],"19+":[143],"months,":[144],"whereas":[145,201],"five":[146],"stable":[149],"disease":[150],"3-15":[152],"months.":[153],"Median":[154],"survival":[155],"from":[156],"initiation":[157],"therapy":[159],"379":[161],"Three":[163],"four":[165],"occurred":[167,174],"nonpulmonary":[169],"locations,":[170],"all":[172],"who":[177],"prior":[180],"nephrectomy.":[181],"MTD":[182],"0.1":[186],"mg/m2/day.":[192],"Toxic":[193],"reaction":[194,206],"limited":[198],"diarrhea,":[200],"principle":[203],"dose-limiting":[204],"toxic":[205],"neutropenia.":[210],"Catheter-related":[211],"complications":[212],"also":[214],"observed.":[215],"CONCLUSIONS:":[216],"Alternating":[217],"active":[228],"treatment":[231],"Whether":[235],"this":[236,250],"regimen":[237,251],"superior":[239],"infusional":[241,264],"undetermined.":[244],"Although":[245],"toxicity":[247],"associated":[248],"manageable,":[253],"it":[254],"appears":[255],"more":[258],"severe":[259],"than":[260],"that":[261],"reported":[262],"alone.":[266]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}